Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Bioceres Crop Solutions (BIOX) Work In Process (2021 - 2022)

Bioceres Crop Solutions' Work In Process history spans 2 years, with the latest figure at $1.3 million for Q2 2022.

On a quarterly basis, Work In Process changed N/A to $1.3 million in Q2 2022 year-over-year; TTM through Jun 2022 was $1.3 million, a N/A change, with the full-year FY2022 number at $1.3 million, changed N/A from a year prior.
Work In Process hit $1.3 million in Q2 2022 for Bioceres Crop Solutions, up from $671000.0 in the prior quarter.
Over the last five years, Work In Process for BIOX hit a ceiling of $1.3 million in Q2 2022 and a floor of $671000.0 in Q4 2021.